Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $0.67 in the prior trading day, Plus Therapeutics Inc (NASDAQ: PSTV) closed at $0.66, down -1.95%. In other words, the price has decreased by -$1.95 from its previous closing price. On the day, 0.49 million shares were traded. PSTV stock price reached its highest trading level at $0.6606 during the session, while it also had its lowest trading level at $0.62.
Ratios:
Our goal is to gain a better understanding of PSTV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.31 and its Current Ratio is at 0.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on March 17, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
On January 25, 2021, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $8.
On October 16, 2020, Maxim Group started tracking the stock assigning a Buy rating and target price of $6.Maxim Group initiated its Buy rating on October 16, 2020, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 13 ’24 when Hawkins Richard J bought 4,000 shares for $1.50 per share. The transaction valued at 5,996 led to the insider holds 15,188 shares of the business.
Hawkins Richard J bought 6,285 shares of PSTV for $8,512 on Sep 12 ’24. The Director now owns 11,188 shares after completing the transaction at $1.35 per share. On Sep 11 ’24, another insider, Petersen Greg, who serves as the Director of the company, bought 12,500 shares for $1.35 each. As a result, the insider paid 16,875 and bolstered with 48,921 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PSTV now has a Market Capitalization of 11195936 and an Enterprise Value of 10956954. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.92. Its current Enterprise Value per Revenue stands at 1.881 whereas that against EBITDA is -0.784.
Stock Price History:
The Beta on a monthly basis for PSTV is 0.96, which has changed by -0.6024096 over the last 52 weeks, in comparison to a change of 0.05430484 over the same period for the S&P500. Over the past 52 weeks, PSTV has reached a high of $2.67, while it has fallen to a 52-week low of $0.24. The 50-Day Moving Average of the stock is -33.25%, while the 200-Day Moving Average is calculated to be -49.09%.
Shares Statistics:
The stock has traded on average 16.24M shares per day over the past 3-months and 2739440 shares per day over the last 10 days, according to various share statistics. A total of 17.00M shares are outstanding, with a floating share count of 16.57M. Insiders hold about 2.55% of the company’s shares, while institutions hold 11.11% stake in the company. Shares short for PSTV as of 1743379200 were 1251464 with a Short Ratio of 0.08, compared to 1740700800 on 140444. Therefore, it implies a Short% of Shares Outstanding of 1251464 and a Short% of Float of 7.4099995000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
